Autologous Point-of-Care Adipose Therapy: Delayed Injury/Scar
Launched by UNIVERSITY OF PITTSBURGH · Feb 26, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to treat scars that form after severe burns or injuries. Specifically, researchers want to find out if a method called autologous layered composite grafting, which involves using the patient’s own fat, is just as effective as traditional skin grafting for improving scars. The goal is to see if this new method can help heal wounds better, reduce scarring, and lower the risk of infections.
To participate in the trial, you need to be an adult aged 18 or older and willing to undergo a procedure to release and reconstruct your scar. The study will include both men and women, including military veterans. If you join, you will receive fat grafting at the same time as having a skin graft to help with the healing process. However, if you have certain health issues, an active infection, or are pregnant, you may not be eligible for the study. The trial is not yet recruiting participants, but it aims to help those with challenging scars find better treatment options.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The proposed study will include adult patients 18 years of age or older,
- • male or female,
- • civilian, military, active duty or retired veterans
- • presenting for scar contracture release and reconstruction at any level.
- • Additional inclusion criteria includes willingness to be randomized to receive a fat graft.
- Exclusion Criteria:
- • Age \< 18 years of age,
- • active infection,
- • medical co-morbidities or anatomic configuration deemed by the physician to be a concern for safety,
- • unwilling or unable to comply with study procedures,
- • radiation to the site of interest,
- • prisoners and/or vulnerable populations.
- • In addition, candidates that are pregnant or plan to become pregnant in the next year, will be excluded.
About University Of Pittsburgh
The University of Pittsburgh is a leading research institution known for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a robust infrastructure for research and a multidisciplinary approach, the university fosters collaboration among experts in various fields, facilitating the development of novel therapies and interventions. Its clinical trial programs emphasize ethical standards, patient safety, and the integration of cutting-edge technology, making the University of Pittsburgh a pivotal contributor to the landscape of clinical research and a trusted partner in the pursuit of health advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Pittsburgh, Pennsylvania, United States
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Francesco Egro
Principal Investigator
University of Pittsburgh
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported